Detalles de la búsqueda
1.
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?
Curr Oncol Rep
; 23(12): 147, 2021 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34748099
2.
Correspondence on 'Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation' by Braaten et al.
Ann Rheum Dis
; 81(1): e13, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31907163
3.
Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients-A Retrospective Observational Study.
Cancers (Basel)
; 15(13)2023 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444532
4.
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials.
Crit Rev Oncol Hematol
; 192: 104190, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37871779
5.
Evaluation of Drug-Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors.
J Pers Med
; 11(5)2021 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34069851
6.
Italian Nivolumab Expanded Access Program in Nonsquamous Non-Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients.
J Thorac Oncol
; 13(8): 1146-1155, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29730379
Resultados
1 -
6
de 6
1
Próxima >
>>